PAINS: the compounds that fake their own activity

Some molecules look like brilliant hits in a screen and turn out to be brilliant liars. They light up across unrelated assays, against unrelated targets, not because they bind anything specifically but because they interfere with the readout itself. These are PAINS — pan-assay interference compounds — and learning to recognize them is one of the cheapest ways to avoid burning months chasing a hit that was never real.

Where the term comes from

Baell and Holloway coined PAINS in a 2010 paper that mined a large high-throughput screening campaign for substructures that turned up as “frequent hitters” far more often than chance allows. Out of that analysis came a set of substructure filters — chemical patterns that flag a compound as statistically likely to be a nuisance. The motifs became famous in their own right: rhodanines, phenolic Mannich bases, hydroxyphenylhydrazones, alkylidene barbiturates, catechols, quinones, 2-amino-3-carbonylthiophenes, and a handful of others. If you have done any literature screening triage, you have seen these scaffolds get waved off on sight.

Why they fool the assay

PAINS do not share a single mechanism. They share an outcome — a false positive — produced through several distinct chemical routes:

• Covalent reactivity — Michael acceptors and other electrophilic motifs (rhodanines, alkylidene heterocycles) react non-specifically with cysteine and lysine residues, knocking out whatever protein is in the well.
• Redox cycling — quinones and catechols generate hydrogen peroxide and reactive oxygen species in the buffer, which then oxidize and inactivate the target. The compound never touches the active site.
• Metal chelation — some scaffolds strip catalytic metal ions out of metalloenzymes, looking like inhibition that is really just cofactor theft.
• Optical interference — intrinsic fluorescence or strong color absorbs or emits at the assay wavelength, faking a signal change with no biology behind it at all.
• Colloidal aggregation — a related promiscuity mode where compounds form aggregates that sequester protein non-specifically. Not strictly a PAINS substructure class, but it rides along in the same triage conversation.

The important caveat: a flag is not a verdict

It is tempting to treat a PAINS match as an automatic reject, and plenty of reviewers do. That is a mistake. The filters were derived empirically from one detection technology, and they over-call: a substructure match means a compound could interfere, not that it does. Several approved drugs contain motifs a PAINS filter would flag. The 2017 reassessment by Baell and Nissink made the point sharply — the right response to a PAINS hit is not the delete key but an orthogonal experiment: run the assay by a second, mechanistically independent readout, check for redox activity, test for aggregation with detergent, and confirm a clean concentration-response. If the activity holds up across orthogonal methods, the compound earns its place regardless of what scaffold it carries.

Where docking fits

Structure-based docking and PAINS are complementary checks that catch different failure modes. Docking asks whether a compound can physically fit and score well in a defined binding pocket. A PAINS flag asks whether an apparent hit might be an assay artifact rather than a real binder. A molecule can dock beautifully and still be a PAINS-driven false positive in the wet lab, because the interference happens in the buffer, not in the pocket. Running both readouts on the same candidate is how you separate a genuine pose from a promiscuous troublemaker before you commit synthesis or assay time.

Try it yourself

Open Studio and dock a candidate against your target. When you review the structural-alert and ADMET readout on the result, treat any PAINS-class substructure match the way you should treat it in real triage: as a prompt to design an orthogonal confirmation, not as a reason to delete a compound that may be perfectly real. Pairing the pose-level evidence from molecular docking with a structural-alert check is the fast way to flag a frequent-hitter scaffold before it costs you a synthesis cycle.

Liganx is molecular docking online: free, browser-based, and built to put the pose score and the liability flags next to each other. If you want to try molecular docking on a hit you are not sure about, that is the fastest path.

Primary sources

• Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53, 2719-2740 (2010). doi:10.1021/jm901137j
• Baell J, Walters MA. Chemistry: Chemical con artists foil drug discovery. Nature 513, 481-483 (2014). doi:10.1038/513481a
• Baell JB, Nissink JWM. Seven year itch: pan-assay interference compounds (PAINS) in 2017 — utility and limitations. ACS Chem Biol 13, 36-44 (2018). doi:10.1021/acschembio.7b00903